SPRC
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- SciSparc says its NeuroThera subsidiary strengthened its U.S. patent portfolio through a collaboration with Clearmind covering LSD, ketamine and ibogaine combinationsSep 23, 2026
- SciSparc's subsidiary NeuroThera Labs pursued FDA Orphan Drug Designation for its adult Tourette syndrome therapy and engaged RK StrategiesSep 7, 2026
- NeuroThera Labs, a SciSparc subsidiary, received a Japanese patent for its proprietary therapeutic combinationAug 12, 2026
- SciSparc's subsidiary NeuroThera Labs launched a Phase IIb trial at Yale for a novel Tourette syndrome treatmentAug 6, 2026
- NeuroThera Labs completed the acquisition of CliniQuantumJun 4, 2026